January 2026

146 Articles

No Section

Critical considerations on uric acid in HFmrEF: from biomarker to metabolic integrator. Author's reply

28 December 2025
Author(s): Alexander Schmitt, Michael Behnes, Ibrahim Akin, Tobias Schupp

Dear Editor,

Oral anticoagulant nonprescription at discharge in geriatric patients with atrial fibrillation and reduced expected survival

17 December 2025
Author(s): Enrico Brunetti, Roberto Presta, Chukwuma Okoye, Claudia Filippini, Silvio Raspo, Gerardo Bruno, Marco Marabotto, Fabio Monzani, Angela Sciacqua, Mario Bo

Oral anticoagulant therapy (OAC), with direct oral anticoagulants (DOACs) recommended over vitamin K antagonists (VKAs), is considered the standard of care for patients with atrial fibrillation (AF)... more

Corrigendum to “Natural history of the severe subtype of MYH9-related disease (Epstein syndrome)” [European Journal of Internal Medicine 138 (2025) 6354]

10 December 2025
Author(s): Kazuma Shinno, Shinji Kunishima, Atsushi Sakamoto, Toru Uchiyama, Akira Ishiguro

The authors regret that an error appeared in Fig. 1 of the published article. The panels for Deafness, Renal failure, and Proteinuria inadvertently displayed the Kaplan-Meier curves for the R702C/H... more

Is left ventricular hypertrophy a reliable predictor of renal and cardiac outcome in IgA nephropathy?

8 December 2025
Author(s): Ernesto Paoletti, Elisabetta Bussalino

Cardiovascular disease (CVD) is the most important cause of adverse clinical outcome in chronic kidney disease (CKD), due to shared etiopathogenetic factors and common pathophysiological mechanisms [... more

The changing landscape of heart failure: translating management into the modern era

5 December 2025
Author(s): Cristina Madaudo, Wasyla Ibrahim, Daniela Noakes, Daniel Bromage, Gianfranco Sinagra, Theresa McDonagh, Antonio Cannata

Heart failure (HF) is a complex clinical syndrome associated with high morbidity and mortality, accounting for approximately 2 % of total healthcare expenditures. Despite advances in pharmacological... more

From networks of data to networks of care in clinical medicine: this is not artificial intelligence

24 November 2025
Author(s): Pierfrancesco Novielli, Roberto Bellotti, Mohamad Khalil, Piero Portincasa, Sabina Tangaro

The increasing availability of clinical, omic, and imaging data in clinical medicine opens unprecedented opportunities to uncover hidden patterns and mechanistic insights into disease. Available... more

Survival effect of early high-flow nasal oxygen after extubation: Statistical, methodological, and ethical concerns

11 November 2025
Author(s): Yukio Umeda

We read with great interest the article by Ishihara et al. evaluating the survival impact of early high-flow nasal oxygen (HFNO) following extubation in intensive care patients [1] Although the... more

Optimising the Caravaggio score: developing a more universally applicable and comprehensive venous thromboembolism risk stratification tool. Author’s reply

24 October 2025
Author(s): Maria Cristina Vedovati, Giancarlo Agnelli

Dear Editor, we thank Wang et al. for their suggestions on potential matters to optimize the Caravaggio score [1]. The recently published Caravaggio score was aimed to stratify the risk of recurrence... more

Renal outcomes following anticoagulation in atrial fibrillation: urgent need for randomized evidence

25 August 2025
Author(s): Costas Platanias, Ioannis Vasileiadis, Ilektra Oikonomopoulou, Elias Sanidas, Costas Thomopoulos

We read with interest the well-written meta-analysis by Adamou et al. [1], focused on studies of atrial fibrillation (AF) patients, investigating the comparative effect of direct oral anticoagulants... more

Beyond the Guidelines

Exporting integration: The southern European internist in the age of specialization

20 November 2025
Author(s): Mayka Freire, Bernardo Sopeña, Emilio Casariego-Vales

If fragmentation is today’s common clinical hazard, the question is which model of Internal Medicine is built to resist it.

Clinical Insights

Integrating the lungs and the nervous system: Redefining chronic obstructive pulmonary disease care

20 December 2025
Author(s): Christian Messina

We read with great interest the article by Mannino et al., which offers a thoughtful and balanced discussion on the clinical relevance of comorbidities in chronic obstructive pulmonary disease (COPD... more

Advances in syncope: Recent evidence and clinical implications

5 December 2025
Author(s): Giacomo Ramponi, Marco Paganuzzi, Monica Solbiati, Giorgio Costantino

The purpose of this article is the synthesis of the most relevant advances in syncope research over the last decade, bridging current practice with future directions across settings of care (... more

Commentary

To dilate or not to dilate: the puzzle of phenotyping heart failure with mildly reduced ejection fraction

31 December 2025
Author(s): Giorgia Esposito, Alberto M. Marra, Antonio Cittadini

Heart failure (HF) is a significant global health concern burdened by an increasingly prevalent issue in both developed and developing countries [1]. It currently affects over 20 million people... more

Intensification of monitoring for improving detection of atrial fibrillation after a presumed “trigger- induced episode” due to potentially reversible factors: what tools and what implications for decision making?

18 December 2025
Author(s): Giuseppe Boriani, Benedetta Cherubini, Davide Antonio Mei

Atrial fibrillation (AF) is an arrhythmia with an increasing epidemiological burden worldwide[1] even if its precise prevalence cannot be defined, since it is frequently asymptomatic, either in... more

Why we measure frailty: Aligning tools with use

17 December 2025
Author(s): Daniele Giuli, Alessandra Ruspi, Graziano Onder

Frailty has become an increasingly prominent topic of investigation, attracting substantial and growing attention within the scientific community. However, such rapid expansion of interest also... more

A call to action: Bridging glucose monitoring and treatment gaps in inpatient diabetes care

5 December 2025
Author(s): Guillermo Umpierrez, Fernando Gomez-Peralta

Diabetes mellitus remains a major global health challenge, increasing clinical, social, and economic burdens on individuals and healthcare systems. In nearly every region of the world, the rising... more

The challenges of anemia management in cardiorenal disease

23 November 2025
Author(s): Elena Ratto, Francesca Viazzi, Elisa Russo

Chronic kidney disease (CKD) and heart failure (HF) are two highly prevalent chronic conditions that together contribute substantially to the global burden of disease. The coexistence of HF and CKD... more

Tezepelumab for severe asthma – an “all round” player

18 November 2025
Author(s): Ophir Freund, Hitasha Rupani, Brian Lipworth, Rory Chan

Many patients with severe asthma who were historically dependent on oral corticosteroids (OCS) for disease control have now entered a new era. Initiation of OCS has become an uncommon event, and many... more

Air pollution: A new avenue for a population-level approach to tackle metabolic dysfunction-associated steatotic liver disease (MASLD)?

28 October 2025
Author(s): Carel-Peter L. van Erpecum

In this issue of the European Journal of Internal Medicine, Di Ciaula et al [1] provide new insights into metabolic dysfunction-associated steatotic liver disease (MASLD) by looking into the... more

Perspective on Epicardial Adipose tissue

25 October 2025
Author(s): Sunil Upadhaya, Rohan Samson, Thierry H. Le Jemtel

In this issue of the European Journal of Internal Medicine, Calcaterra et al. wrote one of the most comprehensive reviews of Epicardial Adipose Tissue (EAT) [1]. In contrast to past dithyrambic EAT... more

Ideas and Opinions

Management of patients without obstructive coronary arteries and suspected microvascular angina: Is it time for a paradigm shift?

29 November 2025
Author(s): Stefano De Servi, Antonio Landi, Bernardo Cortese

Up to 50 per cent of patients undergoing coronary angiography for suspected angina with evidence or not of myocardial ischemia have non-obstructed coronary arteries [1], a condition which is... more

Internal Medicine Flashcard

Recurrent postprandial mandibular swelling with systemic symptoms: a diagnostic challenge

5 January 2026
Author(s): Satoshi Inaba, Ayano Maruyama, Atsushi Kawashima

A 56-year-old woman with allergic rhinitis presented to the emergency department with severe lower abdominal pain and generalized wheals shortly after lunch. Blood tests and abdominal CT were... more

De Winter‐like electrocardiogram changes in the inferior leads

5 January 2026
Author(s): Wenyi Tang, Liyun Luo, Jian Chen

A 48-year-old man with an unremarkable medical history presented with two hours of persistent chest tightness and heartburn. His electrocardiogram (ECG) on arrival showed 1‑ to 3‑mm upsloping ST‑... more

Demyelinating or compressive myelopathy

2 January 2026
Author(s): Christian Messina

A 29-year-old male presented with an eight-month history of progressive ambulation difficulty and a four-month history of urinary hesitancy. He reported no family history of neurological or... more

Double halo sign, abdominal pain and purpura

2 January 2026
Author(s): Romain Batton, Arnaud François, Nicolas Girszyn

A 66-year-old man was admitted to the internal medicine department with subacute abdominal pain and diarrhoea, resulting in a weight loss of 10 kg over three weeks. Shortly thereafter, he developed... more

Perisplenic fibrosis

15 December 2025
Author(s): Tom Abrassart, Olivier Lucidarme, Julien Haroche

Case 1: A 35-year-old woman presented with diabetes insipidus diagnosed at the age of six years. Ten years after diagnosis, she presented with facial sinus infiltration, pleural thickening, long bone... more

A 74-year-old man with skin thickening and ulcers

22 November 2025
Author(s): Ivânia Soares, Inês Pereira Amaral, Paulo Filipe

A 74-year-old man with hypertension, type 2 diabetes (HbA1c 12 %), and chronic kidney disease (KDIGO IIb) presented to the dermatology emergency department with an eight-month history of progressive... more

Recurrent vomiting

5 November 2025
Author(s): Ting Liao, Yuxia Zhu, Xi Liu

A 28-year-old male was referred to the Gastroenterology Department for a 6-year history of recurrent vomiting, occurring 2–3 times daily and exacerbating to >10 episodes per day following cold... more

Woman with progressed gait instability

4 November 2025
Author(s): Jia-Qi Chen, Wei-Nv Fan

An 81-year-old woman presented with progressed gait instability for several months. She had a temperature of about 37.5 °C. The initial neurological examination revealed unsteadiness on the finger-... more

Invited Review Article

Contemporary management of advanced chronic kidney disease: An evidence-based review

22 October 2025
Author(s): Lyle W. Baker, Cene Ovincy, Levon Souvalian, LaTonya J. Hickson, Fouad T. Chebib

Chronic kidney disease (CKD) is a growing global health burden, affecting over 850 million people worldwide and contributing substantially to cardiovascular morbidity, premature mortality, and... more

Letter to the Editor

Advancing beyond multimodality: integrating quantitative imaging biomarkers into the clinical workflow of cardiac amyloidosis. Author’s reply

5 January 2026
Author(s): G Sinigiani, L De Michieli, A. Cipriani

We thank Jiang and colleagues for their interesting Letter [1] and for the generous attention dedicated to our review on multimodality imaging in cardiac amyloidosis (CA) [2]. We greatly appreciate... more

Clinical incidents attended by the internal medicine on-call team at a tertiary care hospital

5 January 2026
Author(s): Victoria Lobo-Antuña, Laura Abenza-Barberá, Francesc Puchades-Gimeno, José Chordá-Ribelles, Sara Carrascosa-García

On-call duty is a cornerstone of hospital-based Internal Medicine, yet it remains one of the least quantified and most debated components of medical practice. Originally conceived to address... more

Environmental PM10 exposure and MASLD: Challenges in translating gene–environment interactions into routine clinical care

5 January 2026
Author(s): Ming Zhuang, JiaMin Qin, Lu Li

We read with great interest the article by Di Ciaula et al. exploring the association between long-term PM10 exposure and metabolic dysfunction-associated steatotic liver disease (MASLD) in... more

Survival outcomes with LUCAS-AssiSTED VS MANUal CPR in in-hospital cardiac arrest obese patients

3 January 2026
Author(s): Saurabh Sujanyal, Ivan Huespe, Aayushi Pareek, Devang Sanghavi, Nick Kelly

Obesity has emerged as a global health challenge, contributing not only to chronic disease but also to poorer outcomes in acute, high-acuity situations such as cardiac arrest. In the in-hospital... more

Reassessing the safety signal: Dihydropyridine calcium channel blockers in the era of quadruple therapy for heart failure. Author's reply

2 January 2026
Author(s): Mauro Gori, Luca Fazzini, Renata De Maria

We read with interest the letter by Wang et al [1] regarding our recently published paper on prescription patterns and outcomes associated with dihydropyridine calcium channel blockers (DHP-CCBs)... more

Methodological and generalizability considerations in the study of bleeding risk with rivaroxaban vs apixaban in older VTE patients

1 January 2026
Author(s): Fuli Liu, Yuanming Ba

We read with great interest the nationwide register-based cohort study by Roupe et al., recently published in the European Journal of Internal Medicine [1]. The authors should be commended for... more

Timing and absolute benefit in updated colchicine meta-analysis for coronary artery disease

30 December 2025
Author(s): Xiaoli Zhu, Pengjun Wang, Xiaoxia Zhang, Chunmei Wang

We read with interest the updated systematic review and meta-analysis by Boracchi and colleagues evaluating long-term secondary prevention with low-dose colchicine in patients with coronary artery... more

“One size does not fit all”: Personalized approach to define appropriate level of palliative care in newly diagnosed idiopathic pulmonary fibrosis patients

30 December 2025
Author(s): Ilaria Bassi, Anna Maria Cuomo, Dino Gibertoni, Gilda Giancotti, Stefano Nava

Idiopathic pulmonary fibrosis (IPF) is still a disease in which patients' clinical needs and the delivery of palliative care (PC) are mismatched. International societies recommend integrating PC for... more

Antiplatelet therapy in patients with stable coronary artery disease who require long-term oral anticoagulation

29 December 2025
Author(s): Laurent Fauchier, Mickael Guglieri, Arnaud Bisson, Thibault Lenormand, Gregory Y.H. Lip

Coronary artery disease (CAD) and atrial fibrillation (AF) and frequently coexist, with overlapping cardiovascular risk factors [1]. Oral anticoagulants (OACs) are indicated for AF-related stroke... more

Refining cardio-kidney-metabolic phenotyping to strengthen interpretation and clinical translation in atrial fibrillation

28 December 2025
Author(s): Qianqian Yang, Jiaqi Xu, Yu Qiu, Ke Chen, Xiangdong Yang

We read with great interest the article by Mei and colleagues, who investigated cardiovascular-kidney-metabolic (CKM) domains in a large European cohort of patients with atrial fibrillation (AF) and... more

SGLT2 Inhibitors in musculoskeletal and connective tissue diseases: Is there a role?

28 December 2025
Author(s): Margarida Lucas Rocha, Vítor Silvestre-Teixeira

Dear Editor,

Reconsidering the prognostic significance of fluid volume fluctuations in kidney failure

26 December 2025
Author(s): Rumeng Tang, Dongsen Hu, Xing Hang, Pengfei Xie, Lili Zhang

We read with great interest the recent study by Zoccali and colleagues regarding the association between long term fluid volume fluctuations and mortality in patients with kidney failure [1]. The... more

Recombinant hf-SCIg in inflammatory myositis: refining patient selection and outcome assessment

23 December 2025
Author(s): Wangqi Tan

We read with great interest the article by Palermo et al. reporting a multicentre real-world experience with recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin (hf-SCIg) for... more

Quality-of-life outcomes after sleeve gastrectomy versus Roux-en-Y gastric bypass: looking beyond mean differences

23 December 2025
Author(s): Adila Abdulla, Chao Li

We read with great interest the article by ’t Hart et al. reporting long-term quality of life (QoL) outcomes after sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in the SleeveBypass... more

Challenges in inpatient diabetes care: A single-day snapshot or a shot at the heart of the problem?

21 December 2025
Author(s): Theocharis Koufakis, Dimitrios Patoulias, Ieva Ruža, Burcu Sallarel, Alexandra Kautzky-Willer

We read with great interest the thoughtful comments from Wang et al. [1] regarding our article, “Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-Lowering Agents: Challenges of... more

Stratifying AF ablation recurrence risk: Limitations of BMI and optimized assessment strategies

21 December 2025
Author(s): Jia Xu, Xiaochen Wang

We read with great interest the article by Liao et al. titled “Both underweight and obese patients are prone to relapse after ablation of paroxysmal atrial fibrillation” published in the European... more

Bronchoscopy, ventilator dose and outcomes in severe CAP: Reading the sex signal. Author's reply

20 December 2025
Author(s): Nicolas Garin, Despoina Koulenti, Virginie Prendki, Jordi Rello

Dear Editor

Heart failure with preserved ejection fraction in the elderly: Clinical, imaging, and biomarker profiles according to global longitudinal strain by cardiac magnetic resonance

15 December 2025
Author(s): Pau Llàcer, Marina García Melero, María Ángeles Fernández, Pedro Torres, Luis Manzano

Dear editor,

Bridging the gap: Phenotype-specific considerations for rituximab therapy in IgG4-related disease. Author's reply

15 December 2025
Author(s): Marco Lanzillotta, Jens Vikse, Elisabetta Goni, Anna-Maria Hoffmann-Vold, Emanuel Della-Torre

We thank Li and Wang for their thoughtful appraisal of our study and for emphasizing the growing need for phenotype-individualized approaches in IgG4-related disease (IgG4-RD) [1,2]. Their comments... more

The widening gap between point-of-care ultrasonography course participation and supervision resources

15 December 2025
Author(s): Antonio Leidi, Aurélie Zacharias-Fontanet, Olivier Grosgurin, DOMUS study group

Dear Editor,

On the urgency of redefining endpoints and precision stratification in extended monitoring for atrial fibrillation

11 December 2025
Author(s): Hangzhou Luo, Jikai Li, Peng Dong

McIntyre et al. have made a significant contribution to the growing body of evidence supporting extended ambulatory electrocardiogram monitoring in patients with transient new-onset atrial... more

Enhancing the clinical relevance of BMI in atrial fibrillation ablation: A call for integrating body-composition and peri-left-atrial adipose tissue measures

11 December 2025
Author(s): Lu Cui, Xi-zhuang Gao, Yong Cao

Liao et al. report a multicentre analysis showing a U-shaped association between pre-ablation BMI and post-ablation atrial tachyarrhythmia recurrence in paroxysmal AF [1]. The work is timely and... more

Beyond ejection fraction: Small left ventricular volumes define a high-risk phenotype in acute heart failure with preserved ejection fraction

10 December 2025
Author(s): Gema Miñana, Ernesto Valero, Hector Merenciano, Vicent Bodí, Julio Núñez

In patients with heart failure and reduced ejection fraction (HFrEF), larger indexed left ventricular volumes (iLVEDV) have been traditionally considered a surrogate of lower left ventricular... more

Communicating robustness and sex-specific benefit of SGLT2 inhibitors in HFpEF and HFmrEF

9 December 2025
Author(s): Qiang Li, Haixu Hao, Xiaoxuan Yue, Meng An, Yun Yue

Dear Editor,

Challenges in defining difficult-to-treat rheumatoid arthritis in the elderly: Channeling bias, sarcopenia, and the age paradox

9 December 2025
Author(s): Changyong Chen, Ji Fei, Haozhu Chen, Yuhai Yan, Kaiwei Zhang

We read with great interest the recent original article by Jung et al., entitled “Difficult-to-treat rheumatoid arthritis among elderly patients from the KOBIO registry,” published in the European... more

Beyond systemic biomarkers: Future directions in understanding the inflammatory nexus of obstructive sleep apnea and atrial fibrillation

8 December 2025
Author(s): Qianhui Niu

We read with great interest the article by Hunt et al. entitled “Systemic markers of inflammation and immune activation in patients with obstructive sleep apnea and paroxysmal atrial fibrillation,”... more

Integrating sTREM2 into non-invasive pathways for early MASH in MASLD

8 December 2025
Author(s): Wenqi Lv, Xiaoyan Yan

We read with great interest the article by Mahmoudian et al., who evaluated soluble triggering receptor expressed on myeloid cells 2 (sTREM2) as a non-invasive biomarker for early metabolic... more

West Nile virus infection: New guitars in town for the internal medicine community

4 December 2025
Author(s): Raffaella Gallo, Iolanda Cafarella, Fabian Patauner, Lorenzo Bertolino, Emanuele Durante-Mangoni

Dear Editor,

Advancing beyond multimodality: integrating quantitative imaging biomarkers into the clinical workflow of cardiac amyloidosis

4 December 2025
Author(s): Yonghao Jiang, Suying Wu, Yuantong Xu

We read with great interest the comprehensive narrative review by Sinigiani et al. titled "Multimodality imaging for cardiac amyloidosis: clinical applications and future directions" published in the... more

Clinical implications of the U-shaped association between body mass index and atrial tachyarrhythmia recurrence after paroxysmal atrial fibrillation ablation

3 December 2025
Author(s): Danni Huang, Linping Zhu

We read with great interest the article by Liao et al., which reported that both underweight and obese patients are at increased risk of atrial tachyarrhythmia (ATa) recurrence after catheter... more

Addressing gaps in inpatient diabetes management: A call for integrated multidisciplinary approaches

2 December 2025
Author(s): Lu Zhang, Peng Zhang

We commend Porth et al. for their timely and insightful study, "Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents," which elucidates critical deficiencies in... more

Tirzepatide as adjunct to insulin for the treatment of type 1 diabetes

2 December 2025
Author(s): Dimitrios Patoulias, Eleftherios Teperikidis, Djordje S. Popovic, Paschalis Karakasis, Theocharis Koufakis

Based on the latest published data, global prevalence of type 1 diabetes (T1D) was 8.4 million individuals in 2021, with 18 % of them being younger than 20 years, 64 % aged 20–59 years and 19 % aged... more

Optimization and clinical applicability of monitoring strategies: further exploration of the monitoring of transient new-onset atrial fibrillation recurrence

2 December 2025
Author(s): Yanqiu Yang, Jie Gao, Xinkang Wang

We read with great interest the study by McIntyre et al. on the monitoring time and recurrence detection rate of transient new-onset atrial fibrillation (AF) [1]. The study provides valuable... more

Direct oral anticoagulant dose optimization in cancer-associated thrombosis: Current evidence and implications for extended therapy

30 November 2025
Author(s): Ursula Medeiros Araujo de Matos, Moana Divina Da Silva Santiago, Patrick Froelich Meldola, Swarup Kumar, Ritika Vankina

Cancer-associated thrombosis (CAT) remains a leading cause of morbidity and mortality. Important risk factors in this population include chemotherapy, hormonal therapies, indwelling catheters or... more

Inpatient diabetes management in Europe: The limits of a single-day snapshot

29 November 2025
Author(s): Binqi Wang, Ruikai Zhang, Juan Jin, Qiang He

We read with great interest the article by Porth et al. [1], titled "Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care... more

Body weight extremes and recurrence risk after ablation of paroxysmal atrial fibrillation

29 November 2025
Author(s): Jun Yang, Hanning Zhang

We read with great interest the recent article by Liao et al., entitled “Both underweight and obese patients are prone to relapse after ablation of paroxysmal atrial fibrillation” [1]. The authors... more

Antibiotic use in hospitalized older adults according to WHO AWaRe classification: data from the REPOSI register

25 November 2025
Author(s): Chiara Elli, Chiara Crippa, Luca Pasina, REPOSI, Investigators

Antimicrobial resistance is a growing global concern and represents a major threat to public health [1]. In response, many countries have implemented guidelines aimed at promoting the rational use of... more

Physical activity in systemic vasculitis

21 November 2025
Author(s): Jozélio Freire De Carvalho, Ana Tereza Amoedo Martinez, Thiago Teixeira Mendes

Dear Editor,

Cardiovascular siRNA therapeutics: A global clinical trial landscape analysis

21 November 2025
Author(s): Han Yan, Haorui Zha, Jiayi Chen, Zhenhui Wang, Linghua Pei

Dear Editor

Bronchoscopy, ventilator dose and outcomes in severe CAP: reading the sex signal

21 November 2025
Author(s): Yulin Liu, Lu Wang

We read with great interest the analysis conducted by Garin et al. regarding sex-related differences in adults intubated for severe community-acquired pneumonia within the EU VAP CAP platform, which... more

Beyond the algorithm: The human interface of medicine

20 November 2025
Author(s): Luca Bonanni, Ada Cutolo

“You should stand at the right side of the patient’s bed.” [1]

Cognitive impairment in familiar hypercholesterolemia: How much is vascular and how much is confounding? Author's reply

18 November 2025
Author(s): Sabrina Scilletta, Antonino Di Pino, Salvatore Piro, Roberto Scicali

We sincerely thank Messina et al. for their thoughtful and valuable comments regarding our study. We fully acknowledge the importance of the points raised and appreciate their contribution to the... more

Bridging the gap: Phenotype-specific considerations for rituximab therapy in IgG4-related disease

15 November 2025
Author(s): Jingyi Li, Jiamin Wang

We were pleased to read the recent article by Goni et al., entitled “Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of... more

Age, sex and DNAR: Re-evaluating the excess-mortality paradox in nonagenarian ICU patients. Author’s reply

14 November 2025
Author(s): Frederik Peters, Jan Frederic Weller, Kevin Roedl, Liesbeth de Wreede, Maximilian Christopeit

Dear Editor,

Mepolizumab improves health-related quality of life in patients with hypereosinophilic syndrome

14 November 2025
Author(s): Florence Roufosse, Maria C Cid, Arunangshu Biswas, Yekaterina Poloz

Hypereosinophilic syndrome (HES) is a rare, heterogeneous disorder, characterised by high eosinophil levels (≥1500 cells/µL) and eosinophilic inflammation leading to multiorgan dysfunction and damage... more

Considerations on socioeconomic and hormonal factors in sex- and gender-specific risk of metabolic syndrome

11 November 2025
Author(s): Aysun Isiklar

We read with great interest the article by Alipour et al. entitled “Role of sex and gender-related variables in development of metabolic syndrome” published in the European Journal of Internal... more

Heart failure with preserved ejection fraction in older inpatients: Where diagnostic algorithms meet geriatric reality

10 November 2025
Author(s): Roberto Presta, Enrico Brunetti, Francesco Palmas, Mario Bo

Heart failure with preserved ejection fraction (HFpEF) represents a growing and increasingly prevalent phenotype of heart failure (HF) in older adults, yet its recognition in routine clinical... more

Left ventricular remodeling in IgA nephropathy — clinical applicability and lessons from real-world practice

4 November 2025
Author(s): Binqi Wang, Juan Jin, Qiang He

I read with great interest the study by Jin[1], which examines the prognostic implications of distinct left ventricular (LV) geometric patterns in patients with biopsy-proven IgA nephropathy (IgAN).... more

Anifrolumab for refractory dermatomyositis: Experience from a Spanish cohort

4 November 2025
Author(s): Jorge Álvarez Troncoso, Elena Sendagorta Cudos, Esther Fiz Benito, Ismael Calero Paniagua, Ángel Robles Marhuenda

Dermatomyositis (DM) frequently remains active despite glucocorticoids and conventional immunosuppressants. A type I interferon (IFN-I) gene-expression signature across skin, muscle, and blood... more

Cognitive impairment and vascular injury in familial hypercholesterolemia: Looking beyond the association

3 November 2025
Author(s): Wei Cui, Yiguo Chen, Zedong Cheng

We read with great interest the article by Sabrina Scilletta et al. published in the European Journal of Internal Medicine, which explored the relationship between cognitive function and subclinical... more

Methodological considerations for interpreting the association between central systolic blood pressure and brain health

3 November 2025
Author(s): Hui Chen

We read with great interest the recent article by Yu et al. (2025) [1] in the European Journal of Internal Medicine, which investigated the association between central systolic blood pressure (cSBP... more

Utility of following morning body weight in patients with hyponatremia due to chronic SIAD

30 October 2025
Author(s): Guy Decaux, Alain Soupart

In patients with chronic hyponatremia, SNa must be maintained above 134 mEq/l to minimize associated morbidity [1].

Traceability of point-of-care ultrasound: The PACS integration process in a tertiary hospital

28 October 2025
Author(s): Yale Tung-Chen, Paloma Oliver, David Castrillo Lázaro

Point-of-Care Ultrasound (POCUS) has become established as an essential diagnostic and therapeutic tool in Internal Medicine, Emergency Medicine, Geriatrics, and other care settings. It allows... more

Tezepelumab in severe asthma: Strengthening real-world evidence and addressing unresolved clinical questions

28 October 2025
Author(s): Jiamin Wang, Jingyi Li

We were pleased to read the recent article by Poto et al. entitled “Effectiveness of tezepelumab in severe asthma: A multicenter real-world study,” published in the European Journal of Internal... more

Meta-analysis of the relationship between internal microplastic and health outcomes

25 October 2025
Author(s): Xiao Liu, Jiaxue Xu, Zexuan Wang, Haisheng Wu, Peng Yu

Dear editor,

Understanding the threat of West Nile virus infection. Comment on prevention and therapy

10 October 2025
Author(s): Salvatore Chirumbolo, Luigi Valdenassi, Umberto Tirelli, Marianno Franzini

We read with interest the article from Gallo et al., which provides a clear and structured overview of the West Nile virus (WNV), particularly valuable for clinicians unfamiliar with its clinical... more

Bolus or continuous for AHF? Lessons from DIUR-AHF. Author's reply

6 October 2025
Author(s): Andrea Salzano, Giulia Crisci, Alberto Palazzuoli

On behalf of the DIUR-AHF investigators, we thank Zhai and Sun for the attention on our research [1] and for the interesting comments provided in their letter to the editor, published in the present... more

Age, sex and DNAR: Re-evaluating the excess-mortality paradox in nonagenarian ICU patients

15 September 2025
Author(s): Renyi Zhu, Jianmin Qu

We read with interest Weller and colleagues’ elegant demonstration that chronological age alone is not associated with excess mortality among nonagenarian ICU patients [1]. Their use of relative-... more

Beyond eligibility – the relevance of individualized heart failure therapy across specialties

12 September 2025
Author(s): Henning Johann Steffen, Tobias Schupp

We read with interest the article by Gencher et al., investigating specialty-related differences in the implementation of guideline-directed medical therapy (GDMT) for patients hospitalized with... more

Bolus or continuous for AHF? lessons from DIUR-AHF

5 September 2025
Author(s): Yuxiao Zhai, Yinghan Sun

With keen interest, we have read the DIUR-AHF study published by Palazzuoli et al. [1], which provides important real-world evidence on loop diuretic strategies in acute heart failure (AHF). The... more

Potassium instability and prognosis in acute heart failure: Practice-oriented reflections

25 August 2025
Author(s): Shaoxiang Huang, Xueyu Wang, Peili Zhang

We read with interest the article, “Association between serum potassium variability during admission for decompensated heart failure and outcomes,” published in the European Journal of Internal... more

Critical considerations on sTREM2 as a biomarker for early MASH in women with severe obesity

21 August 2025
Author(s): Jingyi Li, Xizhuang Gao

We commend Mahmoudian et al. for their insightful study investigating soluble TREM2 (sTREM2) as a noninvasive biomarker for early metabolic dysfunction-associated steatohepatitis (MASH) in women with... more

Phosphatidylethanol and venous thromboembolism risk – clinical implications and future directions

19 August 2025
Author(s): Daniel Matovu

I read with great interest the prospective study by Johansson et al. [1] published in the European Journal of Internal Medicine, which investigates the association between phosphatidylethanol (PEth)... more

Optimizing potassium control in hospitalized heart failure patients: Unanswered questions and future perspectives

18 August 2025
Author(s): Siyu Feng, Quan Zhou, Huaqiang Xu

We read with great interest the recent article by Suzuki et al., recently published in the European Journal of Internal Medicine [1]. The authors address an important and often overlooked aspect of... more

Not just the level – the importance of potassium stability in patients with heart failure

9 August 2025
Author(s): Tobias Schupp, Ibrahim Akin, Michael Behnes

We read with great interest the manuscript by Suzuki et al. investigating the prognostic impact of changes of serum potassium levels during index hospitalization in a large cohort of 1280 patients... more

DOACs vs. VKAs for renal protection: An established superiority gives rise to a new clinical paradox

18 July 2025
Author(s): Ahmed B. Shamsulddin

I commend Adamou and colleagues for their important meta-analysis, which reinforces the established superiority of direct oral anticoagulants (DOACs) over vitamin K antagonists (VKAs) for preserving... more

Original Article

Growth differentiation factor-15 in patients presenting with acute chest pain: Diagnostic and prognostic utility

2 January 2026
Author(s): Luca Crisanti, Jonas Glaeser, Pedro Lopez-Ayala, Luca Koechlin, Paolo Bima, Emel Kaplan, Jasper Boeddinghaus, Lena C. Maeder, Katharina Rentsch, Oscar Miro, Michael Christ, Javier F. Martin-Sanchez, Beata Morawiec, Felix Mahfoud, Ivo Strebel, Christian Mueller, APACE investigators

Each year, over 15 million patients present to the emergency department (ED) in North America and Europe with suspected acute myocardial infarction (AMI) [1,2]. Clinical practice guidelines highlight... more

Residual respiratory events and daytime sleepiness despite management of obstructive sleep apnoea with and without additional central apnoeas. A three-month follow-up study

29 December 2025
Author(s): Michele Vitacca, Beatrice Salvi, Carla Simonelli, Eugenio Vitacca, Giuseppina Gaia, Paola Andreoni, Nicolino Ambrosino, Mara Paneroni

Despite treatment, individuals with obstructive sleep apnoea (OSA) may still exhibit high apnoea and hypopnoea indices (AHI) and excessive daytime sleepiness (EDS). We recorded residual respiratory... more

Recent trends and future projections of atrial fibrillation epidemiology in a large european population

27 December 2025
Author(s): Julián Rodríguez-García, Rafel Ramos, Jordi Blanch, Anna Ponjoan, Paolo D. Dallaglio, Rodolfo San Antonio, Marcos Rodríguez-García, Jordi Mercé, Jesús Rodríguez-Silva, Javier Sanaú, Ismael Almonte, Carlos García-Filloy, Josep Comín-Colet, Ignasi Anguera, Andrea Di Marco

Atrial fibrillation (AF) is a major public health concern with a rising global epidemiological burden and marked regional variability. We analysed AF epidemiology, trends, and future projections in a... more

Risk of endocarditis in patients with bacteraemia by coagulase-negative staphylococci; a multicenter retrospective cohort

27 December 2025
Author(s): Virgile Zimmermann, Nicolas Fourré, Bruno Ledergerber, Jana Epprecht, Berit Siedentop, Pierre Monney, Michelle Frank, Benoit Guery, Georgios Tzimas, Laurence Senn, Lars Niclauss, Matthias Kirsch, Mathias Van Hemelrijck, Omer Dzemali, Barbara Hasse, Matthaios Papadimitriou-Olivgeris

Infective endocarditis (IE) is a serious and under-recognized complication of coagulase-negative staphylococci (CoNS) bacteraemia. The aim was to identify predictors of IE in patients with CoNS... more

Association between interleukin-6, C-reactive protein and chronic kidney disease outcomes: A systematic review and meta-analysis

24 December 2025
Author(s): Sama Mahmoud Abdel-Rahman, Lasin Ozbek, Arif E. Narin, Derya G. Fidan, Zeynep Y. Yilmaz, Helin I. Orak, Mustafa Guldan, Mehmet Kanbay

Chronic kidney disease (CKD) is a progressive disorder defined by structural or functional kidney abnormalities persisting for at least three months. According to KDIGO criteria, CKD is diagnosed by... more

Ultrasound-based evaluation of inspiratory muscle effort in patients with type 2 respiratory failure secondary to exacerbation of chronic obstructive pulmonary disease

16 December 2025
Author(s): Luca Tabbì, Alessandro Marchioni, Jacopo Messina, Sara Bombelli, Daniele Puggioni, Riccardo Fantini, Giulia Bruzzi, Stefania Cerri, Bianca Beghè, Enrico Clini, Roberto Tonelli, MUSE-COPD study group

Exacerbations of chronic obstructive pulmonary disease (ECOPD) are a major cause of acute hypercapnic respiratory failure. Diaphragmatic dysfunction is common, often accompanied by compensatory... more

Fractional exhaled nitric oxide in acute exacerbations of chronic obstructive pulmonary disease: A meta-analysis with meta-regressions

28 November 2025
Author(s): Pasquale Ambrosino, Claudio Candia, Stefano Sanduzzi Zamparelli, Giuseppina Marcuccio, Fabio Manzo, Giorgio Alfredo Spedicato, Christian Basile, Costantino Mancusi, Ennio Lubrano, Guido Grassi, Andrea Motta, Mauro Maniscalco

Fractional exhaled nitric oxide (FeNO) has emerged as a useful tool for monitoring airway inflammation in chronic obstructive pulmonary disease (COPD) patients. We designed a systematic review and... more

Robustness of randomized controlled trial evidence for SGLT2 inhibitors in heart failure with preserved and mildly reduced ejection fraction

27 November 2025
Author(s): Marco Zuin, Pierluigi Temporelli, Claudio Bilato, Alberto Corsini, Fabrizio Oliva, Gianluigi Savarese, Raffaele De Caterina

Sodium–glucose co-transporter 2 inhibitors (SGLT2i) have emerged as a fundamental therapy for patients with heart failure with preserved ejection fraction (HFpEF), a population that has historically... more

Effects of calcium channel blockers on GDMT prescription and outcomes according to ejection fraction: IN-HF real world data

12 November 2025
Author(s): Mauro Gori, Luca Fazzini, Jennifer Meessen, Raul Limonta, Samuela Carigi, Matteo Bianco, Luisa De Gennaro, Concetta Di Nora, Paolo Manca, Maria Vittoria Matassini, Vittoria Rizzello, Denitza Tinti, Aldo Pietro Maggioni, Francesco Orso, Marco Gorini, Renata De Maria, Italian Network on Heart Failure (IN-HF) Investigators

Dihydropyridine calcium channel blockers (DHP-CCB) are widely used in heart failure (HF), despite the lack of data regarding their safety, especially in patients with reduced ejection fraction (HFrEF... more

Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care identified by EFIM’s Diabesity Day Survey 2024

8 November 2025
Author(s): Ann-Kristin Porth, Anete Palma, Burcu Sallarel, Dimitrios Patoulias, Dirk Müller-Wieland, Dror Dicker, Ieva Ruža, Ilya Davidenko, Jan Škrha, Julia Brandts, Ricardo Gomez-Huelgas, Shiran Gruber, Sindija Smirnova, Theocharis Koufakis, Yusuf Ziya Sener, Zuzana Kršáková, Alexandra Kautzky-Willer, EFIM Diabetes and Obesity Working Group

People with diabetes and people with obesity have an increased risk of hospitalisation, tend to have longer hospital stays, and have higher mortality when hospitalised (1–3). Diabetes management... more

Both underweight and obese patients are prone to relapse after ablation of paroxysmal atrial fibrillation

25 October 2025
Author(s): Yu Liao, Chintan Trivedi, Michela Casella, Sanghamitra Mohanty, Luigi Di Biase, Selene Cellucci, Momen Ibrahim, Tejas S Khurana, Wilber Su, J. Peter Weiss, Michael Zawaneh, Antonio Dello Russo, Changsheng Ma, Claudio Tondo, Andrea Natale, Rong Bai

Being overweight has been associated with arrhythmia recurrence after atrial fibrillation (AF) ablation, but the optimal threshold to identify high risk patients has not been well established.... more

Association between long-term exposure to PM10 and metabolic dysfunction-associated steatotic liver disease (MASLD) in subjects with disturbed metabolic homeostasis and genotypes at risk

18 October 2025
Author(s): Agostino Di Ciaula, Marcin Krawczyk, Susanne N. Weber, Mohamad Khalil, Jerlin Stephy JohnBritto, Hala Abdallah, Piero Portincasa

Poor information exists on the role of air pollutants as possible predictors of liver fat over-storage in subjects with increased clinical and genetic risk for MASLD.

Evaluation of the concordance between clinical diagnosis and biopsy in cutaneous vasculitis

14 October 2025
Author(s): Deiner-Yivelson Muñoz-Delgado, Julián-Esteban Barahona-Correa, Daniela Meléndrez-Vásquez, Isabel-Cristina Cuellar-Ríos, Martín-Alonso Rondón-Sepúlveda, Daniel G. Fernández-Ávila, Santiago Bernal-Macías

Cutaneous vasculitis poses a diagnostic challenge due to its variable presentations and overlap with other dermatologic conditions. Although biopsy is essential for confirmation, the concordance... more

Left ventricular remodeling in IgA nephropathy: Prognostic implications and clinical correlations

11 October 2025
Author(s): Lu-Hua Jin, Qian Zhou, Gui-Xin Huang, Yi-Qin Wang, Peng-An Li, Li Tan, Wei Chen, Qiong Wen

The determinants and prognosis of left ventricular (LV) geometric remodeling remain uncharacterized in immunoglobulin A nephropathy (IgAN). We investigated the (1) clinicopathological correlates of... more

Monitoring time-to-detection of recurrent atrial fibrillation in patients with transient new-onset atrial fibrillation detected initially during hospitalization for noncardiac surgery or medical illness

9 October 2025
Author(s): William F. McIntyre, Linda S. Johnson, Alexander P. Benz, Maria E. Vadakken, Nicole R. Latendresse, Chinthanie Ramasundarahettige, Faith Kirabo, Jorge A. Wong, Jason D. Roberts, Jeff S. Healey

Approximately one-third-of patients with transient new-onset atrial fibrillation (AF) during hospitalization for noncardiac surgery or medical illness will have recurrent AF within 1 year when... more

Endothelin-1 as dual marker for renal function decline and associated cardiovascular complications in patients with chronic kidney disease

8 October 2025
Author(s): Laura González-Rodríguez, Manuel Martí-Antonio, Sonia Mota-Zamorano, Celia Chicharro, Bárbara Cancho, Enrique Luna, Álvaro Álvarez, Zoraida Verde, Fernando Bandrés, Nicolás R Robles, Guillermo Gervasini

Cardiovascular (CV) complications are the leading cause of death in patients with chronic kidney disease (CKD). Endothelin-1 (ET-1), a potent vasoconstrictor involved in both renal and vascular... more

Prognostic role of TAPSE/PASP ratio among older patients with acute heart failure and preserved ejection fraction

7 October 2025
Author(s): Giuseppe De Matteis, Amato Serra, Maria Livia Burzo, Francesco De Vito, Maria Anna Nicolazzi, Antonio Iaconelli, Antonio Gasbarrini, Francesco Franceschi, Giovanni Gambassi, Marcello Covino

Right ventricular (RV)-pulmonary circulation (PC) uncoupling is associated with poor outcome in patients with Heart Failure with Preserved Ejection Fraction (HFpEF). Tricuspid annular plane systolic... more

Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry

30 September 2025
Author(s): Davide Antonio Mei, Jacopo Francesco Imberti, Marco Vitolo, Giulio Francesco Romiti, Bernadette Corica, Marta Mantovani, Niccolò Bonini, Benedetta Cherubini, Francisco Marin, Igor Diemberger, Gheorghe Andrei Dan, Tatjana Potpara, Marco Proietti, Gregory Y.H. Lip, Giuseppe Boriani

Cardiovascular, kidney, and metabolic (CKM) conditions frequently coexist with atrial fibrillation (AF), but their impact in AF population remains poorly characterized.

Effectiveness of tezepelumab in severe asthma: A multicenter real-world study

26 September 2025
Author(s): Remo Poto, Gianluca Manganello, Antonio di Salvatore, Ludovica Capitelli, Gianluca Lagnese, Carla Messuri, Tommaso Muto, Fausto De Michele, Gilda Varricchi

Severe asthma is a complex, heterogeneous disease that remains a major therapeutic challenge. Despite several biologics targeting type 2 (T2) inflammation, some patients remain uncontrolled,... more

Non-cardiac surgeries in adults with congenital heart disease -influence of complexity of disease and estimated risk of surgery on adverse events

26 September 2025
Author(s): Alicia Jeanette Friedrich, Robert Radke, Stefan Orwat, Gerrit Kaleschke, Philipp Darius Garthe, Fernando de Torres-Alba, Kevin Willy, Joachim Gerß, Helmut Baumgartner, Gerhard-Paul Diller, Jeanette Köppe

To provide information on adults with congenital heart disease (ACHD) undergoing non-cardiac surgeries (NCS), specific risk compared non-ACHD, independent risk factors for adverse outcome and... more

Short and long term effects of a two-week transcutaneous vagus nerve stimulation in hyperadrenergic postural orthostatic tachycardia syndrome: a proof-of-concept trial

26 September 2025
Author(s): Dana Shiffer, Stefano Rigo, Maura Minonzio, Deniz Timothy Yarsuvat, Eleonora Tobaldini, Ludovico Furlan, Nicola Montano, Beatrice Cairo, Alberto Porta, Antonio Roberto Zamunér, Stefanos Bonovas, Vasile Urechie, Italo Biaggioni, André Diedrich, Raffaello Furlan

autonomic nervous system

Prognostic impact of left ventricular dilatation in heart failure with mildly reduced ejection fraction

16 September 2025
Author(s): Henning Johann Steffen, Michael Behnes, Jonas Dudda, Alexander Schmitt, Noah Abel, Felix Lau, Marielen Reinhardt, Thomas Bertsch, Kathrin Weidner, Daniel Duerschmied, Ibrahim Akin, Tobias Schupp

This study investigated the prognostic value of left ventricular (LV) dilatation in patients with heart failure with mildly reduced ejection fraction (HFmrEF).

Evaluation of cognitive profile and subclinical vascular damage in subjects with genetically confirmed familial hypercholesterolemia

15 September 2025
Author(s): Sabrina Scilletta, Nicoletta Miano, Maurizio Di Marco, Marco Musmeci, Salvatore Carasi, Stefania Capuccio, Claudia Pistritto, Caterina Ippolito, Mariapaola Tiralongo, Antonio Ricci, Maria Chiara Papa, Giosiana Bosco, Francesco Di Giacomo Barbagallo, Antonino Di Pino, Salvatore Piro, Roberto Scicali

Familial hypercholesterolemia (FH) is a genetic lipid disorder characterized by lifelong exposure to high levels of LDL cholesterol (LDL-C), which promotes the progression of atherosclerosis and... more

Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registry

25 August 2025
Author(s): Paolo Prandoni, Meg Fluharty, Sebastian Schellong, Henri Bounameaux, Sylvia Haas, Lorenzo G Mantovani, Sherif Sholkamy, Katsuhiro Kondo, Harry Gibbs, Zhi-Cheng Jing, Chern-En Chiang, Peter Verhamme, Alexander GG Turpie, Jeffrey I. Weitz, Walter Ageno, Shinya Goto, Pantep Angchaisuksiri, Karen Pieper, Ajay K Kakkar, GARFIELD-VTE Investigators

Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is a major cause of morbidity and mortality [1] VTE is linked to several risk factors, including age,... more

Impact of a Checklist-Based Strategy for Cardiac Amyloidosis Screening on Diagnosis Rates in Heart Failure Patients (CHECKAMIC Study)

21 August 2025
Author(s): Alberto Pérez-Nieva, Pau Llàcer, Prado Salamanca-Bautista, Miquel Camafort, Marina García-Melero, Rocio Ruiz-Hueso, Ana Suárez, Carlos Pérez, Irene Bravo-Candela, Raul Ruiz, Anna Aldea, Genoveva López, Cristina Fernández, María del Prado Orduña, Martín Fabregate, Oscar Aramburu-Bodas, Luis Manzano

Amyloidosis is a storage disease caused by the extracellular deposition of fibers derived from structural alterations of unstable proteins, which after folding and aggregation are finally deposited... more

An exploratory model for short-term risk stratification in intermediate-high-risk pulmonary embolism running head: The STAMP score

20 August 2025
Author(s): Marco Zuin, Claudio Bilato, Iolanda Enea, Amedeo Bongarzoni, Franco Casazza, Loris Roncon, Cecilia Becattini

Patients with acute pulmonary embolism (PE) characterized by hemodynamic stability, evidence of right ventricular (RV) dysfunction (RVD), positive cardiac biomarkers and high simplified pulmonary... more

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study

19 August 2025
Author(s): Elisabetta Goni, Jens Vikse, Marco Lanzillotta, Bjørg-Tilde Svanes Fevang, Øyvind Midtvedt, Jasmin Mahajne, Veronica Batani, Giovanni Benanti, Georg Beyer, Lorenzo Dagna, Øyvind Molberg, Katrine Brække Norheim, Ulf Schönermarck, Ivonne Regel, Julia Mayerle, Anna-Maria Hoffmann-Vold, Emanuel Della-Torre

IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition with marked clinical heterogeneity [1]. Common manifestations include autoimmune pancreatitis and cholangitis, orbital... more

Review Article

Prevention and treatment of hypertriglyceridemia-mediated acute pancreatitis: A narrative review

23 December 2025
Author(s): Savitha Subramanian, Handrean Soran, Asia Sikora Kessler, Monica R. McClain, Robert H. Eckel, Robert S. Rosenson

Acute pancreatitis can result in death or serious consequences including chronic pancreatitis, diabetes mellitus, and organ failure. Causes of acute pancreatitis include gallstones, alcohol, and... more

Renal protection in heart failure with reduced ejection fraction: not all that glitters is gold

16 December 2025
Author(s): Elisa Russo, Emilio Venturelli, Giovanna Leoncini, Francesca Viazzi, Roberto Pontremoli

Chronic kidney disease (CKD) is prevalent among patients with chronic heart failure (CHF), largely due to shared risk factors such as hypertension, diabetes, and dyslipidemia. In patients with heart... more

Medical cannabis and the hype cycle: Clinical evidence and future directions

10 December 2025
Author(s): Ran Abuhasira, Victor Novack

Medical cannabis has moved from a taboo subject to a mainstream clinical discussion over the past three decades. This review synthesizes the evidence and frames its progression using a Hype Cycle... more

The neuro-cardiac axis in epilepsy

4 December 2025
Author(s): Theodora A. Manolis, Antonis A. Manolis, Apostolos Vouliotis, Antonis S. Manolis

Epilepsy is one of the major noncommunicable neurological disorders (the other comprising migraine, Alzheimer disease/other dementias, Parkinson’s disease, motor neuron diseases, multiple sclerosis,... more

The evolving landscape of screening, management and treatment strategies of aortic stenosis in ATTR amyloidosis

28 November 2025
Author(s): Aldostefano Porcari, Matteo Serenelli, Rossana Bussani, Gianfranco Sinagra, Lucia Venneri

Transthyretin amyloid cardiomyopathy (ATTR-CM) and aortic stenosis (AS) frequently coexist in elderly patients, particularly men, creating a complex clinical scenario with overlapping symptoms and... more

Cardiovascular Risk Assessment: Practical Tips for the Internal Medicine Specialist

23 November 2025
Author(s): Fernando A. Rivera, Ridwan Ahmad, Jorge Trejo-Gutierrez

Cardiovascular diseases remain the leading cause of mortality worldwide, and they also represent a significant burden in terms of health care expenditure, equipment use, therapeutic interventions and... more

Frailty measurement in research and clinical practice: An updated review

20 November 2025
Author(s): Elsa Dent, Peter Hanlon, Paul Kowal, Emiel O. Hoogendijk

Frailty is a highly prevalent geriatric condition, affecting between 12–24% of older adults globally. It remains a major cause of morbidity and mortality in older adults. Incorporating frailty... more

Drug-induced rise in serum creatinine: cystatin C to the rescue? Evidence, pitfalls and knowledge gaps

11 November 2025
Author(s): Elliott Van Regemorter, Eléonore Ponlot, Lidvine Boland, Valentine Gillion, Arnaud Devresse

Serum creatinine (SCr) concentration is a cheap biomarker of kidney function measured globally millions of times every day. It is part of the KDIGO definitions of both chronic kidney disease and... more

Multidisciplinary strategies and new technologies in the management of sarcoidosis

31 October 2025
Author(s): Claudio Tana, Marjolein Drent, Ogugua Ndili Obi, Francesco Cinetto, Nicol Bernardinello, Livia Moffa, Marco Tana, Dominique Israël Biet, Paolo Spagnolo

Sarcoidosis exemplifies the complexity of modern internal medicine, requiring comprehensive, system-based management. The disease is characterized by non-caseating granulomas and can affect virtually... more

Multimodality imaging for cardiac amyloidosis: clinical applications and future directions

29 October 2025
Author(s): G Sinigiani, L De Michieli, S Nistri, D Cecchin, D Mele, A Cipriani

Systemic amyloidosis are a group of disorders characterized by the extracellular deposition of misfolded protein fibrils [1]. When the heart is involved, the condition is referred to as cardiac... more

ANCA-associated vasculitis and interstitial lung disease: challenges and open questions

20 October 2025
Author(s): Sergio Prieto-González, Raül Jordà-Sánchez, Fernanda Hernández-González, Rona M Smith, David RW Jayne

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic inflammatory disorder that primarily affects small blood vessels, often involving vital organs such as the... more

Anemia in cardiorenal disease: From pathogenesis to treatment

15 September 2025
Author(s): Juan Heng, Zhong-Tang Li, Dan-Dan Yao, Xin-Yan Li, Ming-Xuan Cui, Zuo-Lin Li

Chronic kidney disease (CKD) is a highly prevalent, and progressive comorbidity that affects >10 % of the population worldwide [1–2]. Heart failure (HF) is also a common, disabling, and deadly... more

Earlier Prediction of Cardiovascular Risk with Epicardial Fat Assessment

22 August 2025
Author(s): Giuseppe Calcaterra, Ron T. Varghese, Maurizio Baroni, Alessandro Capucci, Fabio Angeli, Gianluca Iacobellis, Paolo Verdecchia

Obesity is no longer considered a cosmetic problem. The World Health Organisation (WHO) and the European Parliament, as well as many international medical and scientific societies, have recognised... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.